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Behavioral variant frontotemporal dementia (bvFTD) is characterized by deep alterations
in behavior and personality. Although revised diagnostic criteria agree for executive
dysfunction as most characteristic, impairments in social cognition are also suggested.
The study aimed at identifying those neuropsychological and behavioral parameters best
discriminating between bvFTD and healthy controls. Eighty six patients were diagnosed
with possible or probable bvFTD according to Rascovsky et al. (2011) and compared
with 43 healthy age-matched controls. Neuropsychological performance was assessed
with a modified Reading the Mind in the Eyes Test (RMET), Stroop task, Trail Making Test
(TMT), Hamasch-Five-Point Test (H5PT), and semantic and phonemic verbal fluency
tasks. Behavior was assessed with the Apathy Evaluation Scale, Frontal Systems
Behavioral Scale, and Bayer Activities of Daily Living Scale. Each test’s discriminatory
power was investigated by Receiver Operating Characteristic curves calculating the
area under the curve (AUC). bvFTD patients performed significantly worse than healthy
controls in all neuropsychological tests. Discriminatory power (AUC) was highest in
behavioral questionnaires, high in verbal fluency tasks and the RMET, and lower in
executive function tests such as the Stroop task, TMT and H5PT. As fluency tasks
depend on several cognitive functions, not only executive functions, results suggest
Abbreviations: AES, Apathy Evaluation Scale; AUC, area under the curve; BADL, Bayer Activities of Daily Living Scale;
bvFTD, behavioral variant frontotemporal dementia; CDR, Clinical Dementia Rating Scale; DSM, Diagnostic and Statistical
Manual of Mental Disorders; FrSBe, Frontal Systems Behavioral Scale; FTLD, frontotemporal lobar degeneration; FTLD-
CDR, FTLD modified CDR; H5PT, Hamasch-Five-Point Test; ISCED, International Standard Classification of Education;
RMET, Reading the Mind in the Eyes Test; ROC, receiver operating characteristic; TMT, Trail Making Test; ToM, Theory of
Mind.
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that the RMET discriminated better between bvFTD and control subjects than other
executive tests. Social cognition should be incorporated into diagnostic criteria for
bvFTD in the future, such as in the International Classification of Diseases (ICD)-11,
as already suggested in the Diagnostic and Statistical Manual for Mental Disorders
(DSM)-5.
Keywords: behavioral variant frontotemporal dementia, diagnostic criteria, executive function, social cognition,
theory of mind
INTRODUCTION
Behavioral variant frontotemporal dementia, the most frequent
subtype of FTLD, is characterized by deep alterations in
behavior and personality (Neary et al., 1998). By focusing
on clinical symptoms in histopathologically confirmed cases,
an international consortium revised the diagnostic criteria for
bvFTD (Piguet et al., 2011; Rascovsky et al., 2011). Here, ‘possible’
bvFTD is defined by at least three of six clinically discriminating
features: disinhibition, apathy/inertia, loss of sympathy/empathy,
perseverative/stereotyped/compulsive/ritualistic behavior, hype-
rorality/dietary changes and, neuropsychologically, deficits in
executive functioning. Executive functions, also called executive
or cognitive control, represent a wide variety of higher order
cognitive processes enabling flexible modification of thought and
behavior to environmental changes, although the concept is, at
least partly, controversially discussed in the literature. Executive
abilities are essential for coping with changing demands of
everyday life (Miller and Cohen, 2001). Beyond clinical criteria,
biomarkers were additionally included into Rascovsky et al.’s
(2011) disease definition to increase diagnostic validity. ‘Probable’
bvFTD requires specific (frontotemporal) neuroimaging findings,
whereas bvFTD ‘with definite FTLD’ has to be supported by
histopathological confirmation or a pathogenic mutation. The
new revised criteria have a much higher sensitivity in comparison
to the earlier ones (Neary et al., 1998).
Remarkably, the new DSM-5, published in 2013, has included
a prominent decline in social cognition in addition to executive
dysfunction to bvFTD’s criteria, here called frontotemporal
neurocognitive disorder (American Psychiatric Association,
2013). In analogy to Rascovsky et al. (2011), three behavioral
symptoms have to be fulfilled, and validity is increased
by neuroimaging and/or causative genetic mutations. Social
cognition includes cognitive processes that are important for
social interactions (Moskowitz, 2005). It enables recognizing,
manipulating, and behaving with respect to socially relevant
information (Poletti et al., 2012). Here, social signals have
to be perceived and connected to motivation, emotion, and
adaptive behavior. One central concept of social cognition
is ToM or ‘mentalizing’ referring to the ability to attribute
mental states to self and others and to describe, explain and
predict behavior on the basis of such mental states (Frith and
Frith, 2003; Amodio and Frith, 2006; Poletti et al., 2012). Two
components of ToM have been suggested recently, a cognitive
component focussed on processing other people’s beliefs and
intentions, and an affective component focalized on processing
others’ emotions and feelings (Poletti et al., 2012). Several
studies have shown specific deficits in social cognition/ToM in
bvFTD (Gregory et al., 2002; Rankin et al., 2006; Adenzato
et al., 2010; Henry et al., 2014; Schroeter et al., 2014) even
predicting its development (Pardini et al., 2013). Whereas
performance in ToM tasks does not correlate with executive
functioning in early bvFTD, ToM ability and executive functions
become strongly related in advanced disease (Seelaar et al.,
2011).
In sum, there is consensus in the literature that patients
with bvFTD show profound changes in personality/behavior and
that bvFTD affects executive functions (Rascovsky et al., 2011;
American Psychiatric Association, 2013). Impairments in social
cognition are regarded as a neuropsychological and diagnostic
hallmark by some authors (American Psychiatric Association,
2013), whereas others regard it as less relevant (Rascovsky et al.,
2011) or an epiphenomenon of executive dysfunction (Le Bouc
et al., 2012; Schroeter et al., 2014).
To investigate the relevance of social cognition in diagnosing
bvFTD clinically, we examined the discriminatory diagnostic
power for several neuropsychological tests in a large sample of
bvFTD patients compared with age-matched healthy subjects
from the multi-centric FTLD consortium’s study Germany (Otto
et al., 2011). We applied the new diagnostic criteria for bvFTD
(Rascovsky et al., 2011). Tests assessed executive functions, social
cognition, and behavioral parameters. Recently, Miyake et al.
(2000) have suggested that executive control comprises three
core processes, namely working memory, task switching and
inhibitory control. To cover these aspects we used different
tests for fluency, divided attention and inhibition of overlearned
responses. Based on previous studies we hypothesized that
executive function tests, in particular verbal fluency tests, are
good predictors for bvFTD (Pachana et al., 1996; Galante et al.,
1999; Gregory, 1999; Pasquier et al., 1999; Perry and Hodges,
2000).
Recent investigations emphasized a dominant role of social
cognition in the early diagnosis of bvFTD and suggested that
these tests might constitute a better diagnostic predictor than
traditional executive tests (Gregory et al., 1999, 2002; Hodges,
2007; Torralva et al., 2009; Adenzato et al., 2010; Poletti et al.,
2012; Adenzato and Poletti, 2013; Pardini et al., 2013; Bora
et al., 2015). Accordingly, we further hypothesized that bvFTD
patients show a decline in social cognition as compared to healthy
controls and that social cognition tests have more diagnostic
power in the identification of bvFTD than traditional tests of
executive functions. Here, we applied a test covering cognitive
and affective components of ToM. Finally, we hypothesized
that informant-report questionnaires are more sensitive than
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self-report questionnaires in detecting behavioral changes in
bvFTD due to unawareness in these patients (Schroeter et al.,
2014).
MATERIALS AND METHODS
Patients
Data were provided by the multi-centric FTLD consortium’s
study Germany (Otto et al., 20111). The cohort included 86
patients diagnosed with possible and probable bvFTD according
to Rascovsky et al. (2011) and 43 healthy age-matched control
subjects. Note that, accordingly, deficits in social cognition
were not included in the diagnostic criteria thereby preventing
a circular study design. Patients and control subjects were
age-matched on a two to one basis within the range of
±4 years. The standardized protocol included a range of
clinical, neuropsychological, brain imaging, and cerebrospinal
fluid biomarker assessments. The study was approved by the
ethics committees of all Universities contributing patients and
controls, and was in accordance with the latest version of the
Declaration of Helsinki (ethics committee Leipzig ID 137-11-
18042011). Each participant provided written informed consent.
Neuropsychological and Behavioral
Tests
In the following, clinical rating scales, questionnaires, and
neuropsychological tests are described. The CDR evaluates
the severity and stage of dementia (Morris, 1993). Because
CDR was originally designed for Alzheimer’s disease, an
FTLD-CDR was additionally included considering also
behavior/personality and language (Knopman et al., 2008;
range 0–18/24). Education was operationalized with the ISCED
into seven levels (Organization for Economic Co-Operation and
Development, 1999).
Questionnaires were conducted based on informant- and self-
report. The AES quantifies and characterizes apathy (range 0–54;
Marin et al., 1991). The BADL rates global difficulties in everyday
life activities (range 1–10; Hindmarch et al., 1998). The modified
FrSBe measures behavior associated with frontal lobe damage
(subscales apathy, disinhibition, executive dysfunction; range
24–120; Grace and Malloy, 2001).
Neuropsychological tests assessed executive functions and
social cognition. The Stroop color-word interference task measures
interference resolution and response inhibition (percentage of
correct answers in 45 s; MacLeod, 1991). Subjects are requested
to name the color of a word with an incongruent meaning. By
doing this they have to inhibit an overlearned response (reading)
in favor of a novel response (color naming) (Schroeter et al.,
2002, 2004). The TMT consists of two parts. Part A requires
subjects to connect numbers, whereas in Part B an alternating
sequence between numbers and letters has to be drawn. Thus,
Part B assesses mental flexibility and divided attention (Lezak
et al., 2012). The B/A ratio for completion time as used in
our study measures executive function (Arbuthnott and Frank,
1http://www.ftld.de
2000). A further aspect of executive functions is spontaneous
divergent thinking. The H5PT assesses figural divergent thinking
or figural fluency (Haid et al., 2002). Subjects have to connect
five point boxes in varying ways to create as many different
patterns as possible (percentage of correct patterns within three
min). Executive functions can also be evaluated by verbal fluency
tests. In these tests, subjects have to produce as many words
as possible that begin with a specific letter (phonemic fluency;
s-words) or belonging to a specific category (semantic fluency;
animals) (Crawford and Henry, 2005) (correct answers within
one min). Besides assessing spontaneous divergent thinking, the
test also provides information about speech ability and, in the
case of the categorical task, about semantic memory capabilities
(Morris et al., 1989; Lezak et al., 2012). Finally, a modified RMET
was applied to measure aspects of social cognition. Here, 18
photographs of the eye-region of human faces are presented
to the subject (Baron-Cohen et al., 2001). Additionally, six
photographs of the human eye-region contained basic emotions
resulting in 24 items in total. Accordingly, the test covered
both cognitive and affective components of ToM. As shown in
a recent comprehensive meta-analysis, bvFTD patients showed
substantial impairment on ToM and emotion recognition tasks
compared with healthy controls, without significant differences
between both measures, justifying its combination (Henry et al.,
2014). Subanalyses were not performed due to low respective
item numbers. In the task, the subject is required to choose
among four adjectives describing what the individual in the
photography is thinking or feeling (number of correct answers).
The RMET is considered an advanced test of ToM, as it assesses
how accurately one can recognize emotions or mental states
in facial expressions, which is a central construct of social
cognition.
Statistical Analysis
Statistical analyses were performed using Statistical Package for
Social Sciences (SPSS) 20.0 (IBM Corporation, Armonk, NY,
United States). Normal distribution was tested separately for
the patient and control group with Kolmogorov–Smirnov tests
for all variables. Even after logarithmic transformation most
of the parameters were not normally distributed. Hence, we
relied on non-parametric tests (Mann–Whitney U test). For each
comparison the non-parametric effect size rcontrast was calculated
with the formula r = Z√
N
(Rosenthal and DiMatteo, 2001).
Here, Z is the standardized test statistic. Results are reported as
mean ± standard deviation, if not stated otherwise. Significance
levels were set to p < 0.05 with Bonferroni adjustments
by taking the respective number of neuropsychological
tests or behavioral questionnaires into account (accordingly
adjusted p < 0.008 with six neuropsychological tests, and
p < 0.006 with eight behavioral questionnaires). Effect sizes
were interpreted as small (0.1 ≤ r ≤ 0.3), intermediate
(0.3 < r ≤ 0.5) or strong (0.5 > r) according to Cohen
(1988).
To explore which test parameters differentiate best between
bvFTD and control subjects, non-parametric ROC curves were
calculated for each test. ROC analysis is commonly used to
quantify how accurate medical diagnostic tests discriminate
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between diseased and non-diseased subjects. The ROC curve as
a graphical plot illustrates the performance of a binary classifier
system when its discrimination threshold is varied. It shows the
trade-off between true positive rate (sensitivity) and false positive
rate (1-specificity) (Metz, 1978, 1986). The AUC was calculated as
an effective and combined measure of sensitivity and specificity
determining a test’s ability to discriminate between diseased and
healthy populations. Here, an AUC of 1 represents a test with
perfect discrimination, while an AUC of 0.5 is interpreted as
useless (Hanley and McNeil, 1982).
Due to missing values in neuropsychological and behavioral
parameters in our dataset (see Table 2), a missing data
analysis was performed as missing data might complicate the
interpretation of results (Ware et al., 2012). This analysis
was conducted with the Missing Value Analysis procedure
of SPSS 20.0, IBM Statistics. It revealed that most values
were missing in self-report behavioral questionnaires in the
bvFTD group, and the TMT. Datasets of some specific study
centers showed similar missing patterns. In the further analyses,
the technique of pairwise deletion was used to deal with
missing values and to include all data available for each
case.
RESULTS
Clinical and Epidemiological
Characteristics
There were no differences between bvFTD and control subjects
for age (63.9 ± 9.6 vs. 66.1 ± 10.1 years; Student’s t-test
t(127) = −1.18, p = 0.24), gender (female/male 38/48 vs. 22/21;
χ2-test χ2(1, N = 129) = 0.56, p = 0.45), and education (3.6± 1.2
vs. 3.8 ± 1.3; Mann–Whitney U test U = 1632.5, p = 0.26). The
patient group included 37 (43%) possible bvFTD and 49 (57%)
probable bvFTD patients according to Rascovsky et al. (2011).
In the following we will report data for the whole bvFTD group
yielding sufficient statistical power. The FTLD-CDR score for the
bvFTD group was 8.4± 5.4 and for the control subjects 0.1± 0.3,
the CDR score averaged 6.2 ± 4.3 and 0.1 ± 0.2 (U = 5.5, 8.0,
p < 0.001).
Neuropsychological Tests – Group
Comparisons
Performance in neuropsychological tests is shown in Table 1.
Concerning executive functions and social cognition, the bvFTD
group showed a significant decline as compared to healthy
controls in every test, also after Bonferroni correction. Effect
sizes were strong for fluency tests (phonemic/semantic fluency
r = −0.72/−0.69), followed by the modified RMET (−0.64) and
H5PT (−0.50), whereas intermediate effect sizes emerged for the
Stroop task and TMT (−0.35 for both).
Behavioral Questionnaires – Group
Comparisons
Table 1 summarizes results for the behavioral questionnaires.
In almost all behavioral questionnaires bvFTD patients showed
a significant dysfunctional change in behavioral patterns as
compared to healthy controls. Only the group difference for the
degree of distress caused by dysfunctional behaviors as measured
with the FrSBe self-report was not significant after Bonferroni
correction.
Effect size analyses revealed higher values for informant-
than self-report for frequency (r = −0.64/−0.40) and distress
(−0.64/−0.30) caused by dysfunctional behaviors as measured
with the FrSBe. Effect sizes of the FrSBe were strong for
the informant-report and intermediate for the self-report. An
analog pattern was found for the AES evaluating apathy. Here,
informant-report (−0.61) indicated higher impairment than self-
report (−0.55), although for both measures effect size was
strong for discrimination between bvFTD and control subjects.
Remarkably, for the BADL evaluating difficulties in activities
of daily life the informant-report reached strong (−0.59) and
the self-report reached intermediate effect size (−0.42), without
differences between both measures.
Discriminating between Groups –
Receiver Operator Characteristic (ROC)
Curves
To explore how well the single neuropsychological tests or
behavioral questionnaires discriminate between bvFTD and
controls, we computed a non-parametric ROC curve for each
parameter as illustrated in Figures 1, 2. The CDR and FTLD-
CDR discriminated almost perfectly between bvFTD patients and
healthy controls (Figure 1). The Stroop task, TMT, and H5PT
had a higher specificity than sensitivity. Phonemic and semantic
fluency tasks as well as the modified RMET on the other hand
showed relatively balanced sensitivity and specificity. Figure 2
illustrates that the AES in the self-report had a greater sensitivity
than specificity. The graphical illustrations of the other behavioral
questionnaires (AES in informant-report, BADL in both versions,
and FrSBe in both versions) showed relatively balanced ratios of
sensitivity and specificity.
To investigate the discriminatory power in distinguishing
between bvFTD and control subjects the AUC was calculated
for each single test. Results are shown in Table 2 and Figure 3.
Discriminatory power was highest for CDR and FTLD-CDR,
and for the informant-report behavioral questionnaires, whereas
the self-report questionnaires reached much lower values. The
discrepancy between informant- and self-report was highest for
FrSBe and BADL, and lower for AES. For neuropsychological
tests, semantic and phonemic fluency reached highest values
for discriminatory power, closely followed by the modified
RMET, whereas the H5PT, TMT and Stroop task showed lowest
discriminatory power as reflected in the AUC values.
DISCUSSION
Our study investigated changes in neuropsychological functions
in bvFTD with a focus on executive functions and social
cognition, which are the cognitive dimensions mainly impaired
in this disease affecting essentially frontal lobes (Rascovsky et al.,
2011; American Psychiatric Association, 2013; Schroeter et al.,
Frontiers in Aging Neuroscience | www.frontiersin.org 4 January 2018 | Volume 10 | Article 11
fnagi-10-00011 January 27, 2018 Time: 14:30 # 5
Schroeter et al. Executive and Social Cognition in bvFTD
TABLE 1 | Statistics for neuropsychological tests and behavioral questionnaires – Comparison between bvFTD and healthy control subjects.
bvFTD patients Healthy controls
Median Mean (SD) Median Mean (SD) U Z p r
Neuropsychological tests
Stroop task 96.7 86.18 (22.69) 100 98.87 (2.91) 552 −3.378 0.001∗ −0.35
Trail Making Test (TMT) 2.79 2.92 (1.16) 2.11 2.13 (0.45) 609.5 −3.391 0.001∗ −0.35
Hamasch Five-Point Test (H5PT) 77 67.31 (27.53) 95 93.65 (6.02) 414.5 −5.007 <0.001∗ −0.50
Phonemic fluency 7 7.41 (4.90) 18 17.83 (4.55) 192.5 −7.776 <0.001∗ −0.72
Semantic fluency 11 12.46 (6.71) 26.5 26.48 (4.72) 171 −8.079 <0.001∗ −0.69
Reading the Mind in the Eyes Test (RMET) 11 10.83 (3.79) 16 16.71 (2.56) 214.5 −6.272 <0.001∗ −0.64
Behavioral questionnaires
Apathy Evaluation Scale (AES), self-report 21 20.26 (9.64) 9 9.79 (4.91) 91.0 −3.696 <0.001∗ −0.55
Apathy Evaluation Scale, informant-report 36 34.95 (10.00) 9 11.73 (6.63) 42.5 −5.504 <0.001∗ −0.61
Bayer Activities of Daily Living Scale
(BADL), self-report
1.88 3.03 (2.66) 1.38 1.46 (0.46) 158.0 −2.933 0.003∗ −0.42
Bayer Activities of Daily Living Scale,
informant-report
5.68 5.68 (2.79) 1.26 1.40 (0.50) 40.5 −5.395 <0.001∗ −0.59
Frontal Systems Behavioral Scale (FrSBe),
frequency, self-report
45 51.04 (20.81) 36 37.00 (8.47) 153.5 −2.777 0.005∗ −0.40
Frontal Systems Behavioral Scale,
frequency, informant-report
72 73.10 (17.97) 31 34.80 (9.35) 27.0 −5.650 <0.001∗ −0.64
Frontal Systems Behavioral Scale, distress,
self-report
36 39.18 (14.09) 28 31.82 (10.14) 158 −1.989 0.047 −0.30
Frontal Systems Behavioral Scale, distress,
informant-report
58.5 60.47 (17.15) 24 27.46 (6.00) 16.5 −5.365 <0.001∗ −0.64
Significant with Bonferroni adjusted alpha level of ∗p < 0.008 for neuropsychological tests, p < 0.006 for behavioral questionnaires; Abbreviations: r, effect size;
SD, standard deviation; U, Mann–Whitney U; Z, test statistic of Mann–Whitney U.
FIGURE 1 | Receiver Operating Characteristic curves for the CDR, the CDR specified for FTLD (FTLD-CDR), and for the several neuropsychological tests, namely
the Stroop test, H5PT, semantic and phonemic fluency, TMT, and the RMET.
2014). The study was conducted in a large multi-centric sample
and applied the new and revised diagnostic criteria by Rascovsky
et al. (2011). In particular, the study examined the question
whether a modified RMET as a measure for social cognition
might predict bvFTD equal to or even better than executive
function tests. In the following we will discuss the study’s results.
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FIGURE 2 | Receiver Operating Characteristic curves for the behavioral questionnaires, in particular the AES, BADL, and the FrSBe. Informant- and self-report
measures are shown.
TABLE 2 | Statistics for neuropsychological tests and behavioral questionnaires in discriminatory power between bvFTD and healthy control subjects – Results of the
AUC analyses.
Available values (%)
Area Under Curve (AUC) Confidence Interval p bvFTD Controls
Dementia severity measures
Clinical Dementia Rating Scale (CDR) 0.997 0.992–1.000 <0.001 84.9 93
Frontotemporal Lobar Degeneration (FTLD-)-CDR 0.998 0.994–1.000 <0.001 84.9 93
Neuropsychological tests
Stroop task 0.698 0.593–0.803 0.002 73.3 67.4
Trail Making Test (TMT) 0.707 0.601–0.813 0.001 60.5 93
Hamasch Five-Point Test (H5PT) 0.812 0.730–0.893 <0.001 82.6 72.1
Phonemic fluency 0.937 0.893–982 <0.001 87.2 95.3
Semantic fluency 0.948 0.910–0.985 <0.001 90.7 97.7
Reading the Mind in the Eyes Test (RMET) 0.895 0.835–0.955 <0.001 76.7 72.1
Behavioral Questionnaires
Apathy Evaluation Scale (AES), self-report 0.823 0.701–0.944 <0.001 31.4 44.2
Apathy Evaluation Scale, informant-report 0.957 0.915–0.999 <0.001 76.7 34.9
Bayer Activities of Daily Living Scale (BADL), self-report 0.744 0.606–0.881 0.003 32.6 51.2
Bayer Activities of Daily Living Scale, informant-report 0.959 0.918–0.999 <0.001 81.4 32.6
Frontal Systems Behavioral Scale (FrSBe), frequency, self-report 0.734 0.587–0.880 0.006 27.9 55.8
Frontal Systems Behavioral Scale, frequency, informant-report 0.971 0.939–1.000 <0.001 73.3 34.9
Frontal Systems Behavioral Scale, distress, self-report 0.674 0.508–0.839 0.049 25.6 51.2
Frontal Systems Behavioral Scale, distress, informant-report 0.978 0.946–1.000 <0.001 67.4 30.2
Executive Function Tests Are Good
Predictors for bvFTD
Our study confirmed that bvFTD is related to a significant
decline in executive functions as demonstrated for all executive
tests (Stroop task, TMT, H5PT, semantic and phonemic
fluency). Results confirm earlier studies showing that executive
functions including planning, organization, judgement, problem
solving and mental flexibility are highly impaired in bvFTD
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FIGURE 3 | Discriminatory power as measured with Areas Under the Curve (AUC) as revealed by ROC curves for the AES, BADL, CDR, CDR specified for FTLD
(FTLD-CDR), FrSBe, H5PT, RMET, and TMT.
(Gregory and Hodges, 1996). Interestingly, the most frequent
finding was a constant deficit in the ability to produce semantic
and phonemic wordlists (Pachana et al., 1996; Galante et al., 1999;
Gregory, 1999; Pasquier et al., 1999; Perry and Hodges, 2000).
In line with these studies, verbal fluency tests predicted bvFTD
better than other gold standard tests for executive functions like
the H5PT, Stroop task, or TMT in our study as demonstrated by
respective AUC values. Obviously, several executive tests tap into
different aspects of executive functions and not all of these aspects
are equally relevant for everyday life (e.g., Rabbitt, 1997; Torralva
et al., 2009; Schroeter et al., 2012). Verbal fluency tests are
based on the ability of spontaneous divergent thinking involving
working memory, speech ability, attention and memory, whereas
the other executive function tests are related to the ability to
draw abstract patterns (H5PT), to connect alternating numbers
and letters (TMT) as a measure of divided attention or to
inhibit an overlearned response (Stroop task) (Rabbitt, 1997;
Haid et al., 2002; Schroeter et al., 2002, 2012; Torralva et al.,
2009). However, one has to keep in mind that deficits in executive
functions, although prominent in bvFTD, are by far not disease-
specific as they occur in other neurodegenerative diseases such as
Alzheimer’s disease too (Schroeter et al., 2012). Already, Gregory
et al. (1999, 2002) and Hodges (2007) criticized that executive
function tests may fail to detect the onset of cognitive impairment
in bvFTD patients.
Social Cognition Tests Seem to Be Better
Predictors for bvFTD
Most interestingly, our results for the modified RMET as
one measure for ToM/social cognition provide evidence for a
significant decline in recognition of mental/emotional states in
bvFTD. Indeed, the RMET was a better diagnostic predictor
for the diagnosis of bvFTD than executive measures such as
the Stroop task, TMT and H5PT. Obviously, the RMET is
related, beside others, to verbal abilities, since it requires the
differentiation between semantically similar adjectives describing
the person’s mental state, indicated by the eyes. This might, at
least partly, explain comparable discriminatory power between
the modified RMET and verbal fluency tasks. Other executive
tasks rely less on verbal content (Stroop, TMT, and H5PT). We
checked this hypothesis with a multiple regression analysis using
the modified RMET as dependent variable and executive function
tests as independent variables. Indeed, this analysis identified
semantic fluency as the only significant parameter (beta = 0.52,
T = 3.1, p = 0.004).
Our results are in line with previous research showing that
ToM is a good diagnostic predictor for bvFTD (Gregory et al.,
2002; Torralva et al., 2009; Adenzato et al., 2010) in agreement
with the assumption that the frontomedian cortex, related to
ToM processing (Amodio and Frith, 2006), has been regarded as
the neural ‘hot-spot’ of bvFTD (Schroeter et al., 2008, 2011, 2014;
Schroeter and Neumann, 2011; Schroeter, 2012; Meyer et al.,
2017). A recent meta-analysis by Henry et al. (2014) involving
800 subjects confirmed the central role of ToM by showing
significantly higher and domain-specific impairments in ToM
(and emotion recognition) in bvFTD in comparison with control
subjects and Alzheimer’s disease. Another new comprehensive
systematic meta-analysis across 30 clinical conditions including
multiple psychiatric, neurological and developmental disorders
has replicated specific and strongest social cognitive dysfunction
in bvFTD (large effect size with Cohen’s d −1.79 for ToM and
−1.81 for facial emotion recognition; Cotter et al., 2018). To
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place our results into this framework we calculated effect sizes
for the group comparison bvFTD vs. control subjects of the
modified RMET in our study similar to Cotter et al. (2018).
Remarkably, analyses revealed similar effect sizes of Cohen’s
d = − 1.82 and Hedges’ g = − 1.702. Specifically the RMET has
been shown to predict very early bvFTD (Pardini et al., 2013),
and to discriminate better between bvFTD and healthy controls
or Alzheimer’s disease than executive tests (Gregory et al., 2002;
Torralva et al., 2007, 2009; Gleichgerrcht et al., 2010; Buhl et al.,
2013). Although verbal fluency tests performed comparable to
the modified RMET in our study, they are based on several
cognitive functions/abilities (see above) making these measures
less specific for executive functions than other executive function
tests such as the H5PT, TMT or Stroop task. Moreover, executive
functions tests are not disease-specific in contrast to the social
cognition tests such as the RMET for the differential diagnosis
across different forms of dementia (see above).
Based on our results and literature data one can conclude that
social cognition tests, such as the RMET, are better and more
disease-specific predictors for bvFTD than executive function
tests. One might object that empathy is already contained in
the diagnostic criteria for bvFTD making the inclusion of social
cognition/ToM redundant (Rascovsky et al., 2011; American
Psychiatric Association, 2013). However, ToM refers to the
cognitive understanding of an emotional or mental state, while
empathy refers to the emotional sharing of an emotional state
(Hein and Singer, 2008; Bzdok et al., 2012). Neural correlates
of empathy and ToM are regionally dissociated and overlap
only partly (Bzdok et al., 2012; Schroeter et al., 2014). We
suggest including a decline of social cognition/ToM in future
revisions of the diagnostic criteria for bvFTD in the International
Classification of Diseases (ICD) version 11 by the World Health
Organization as already suggested by the DSM-5 to increase their
specificity, reliability and predictive power (Schroeter, 2012).
Behavioral Questionnaires Are Best
Predictors for bvFTD
Finally, we want to discuss results for behavioral measures.
The three questionnaires AES, BADL and FrSBe showed in
both versions (self-report and informant-report) a significant
increase of dysfunctional behavioral patterns and everyday
life difficulties in bvFTD as compared to healthy controls.
The informant-reports were consistently better diagnostic
predictors for bvFTD than self-reports reflecting the lack of
patient’s insight concerning their disease and emphasizing the
importance of informant-reports for correct and early diagnosis
of bvFTD.
The informant-report of the FrSBe, which assesses typical
behavioral patterns of the frontal system, including apathetic,
disinhibited behavior, and executive functions in daily living,
showed a higher diagnostic prediction of bvFTD than the AES.
The latter test exclusively focuses on apathy. A similar advantage
of the FrSBe emerged against the BADL, a scale taping into
general difficulties in everyday activities. The higher prediction of
bvFTD by the FrSBe can be explained by the fact that it assesses
2http://www.socscistatistics.com/effectsize/Default3.aspx
more than only one single dysfunctional behavioral pattern.
Although less than the informant-reports, self-reports also
indicated significantly more dysfunctional behavioral patterns in
bvFTD than in healthy controls. The bvFTD patients did thus
have at least some insight into the disease. Interestingly, apathy
as assessed in the AES self-report questionnaire had the highest
AUC in self-reports as compared to the BADL and the FrSBe,
which might be related to a selective loss of insight. This pattern is
also mirrored in an item-specific AUC analysis of the FrSBe scale,
where patients’ self-report for apathy discriminated better than
self-report for executive dysfunction or disinhibition (Figure 4).
Dysfunctional behavioral patterns as assessed by AES, BADL
and FrSBe in the informant-report were better predictors
of bvFTD than all other neuropsychological (executive and
social cognitive) tests investigated. Although not surprising as
diagnostic systems define bvFTD exactly by these behavioral
impairments (Rascovsky et al., 2011; American Psychiatric
Association, 2013), our results suggest that dysfunctional
behavioral patterns shall be measured with quantitative
instruments for a reliable and correct early diagnosis of bvFTD
in clinical routine in addition to assessing neurocognitive decline
with neuropsychological tests.
Limitations of the Study and
Perspectives
Several caveats should be kept in mind when considering
the current results. Although the multi-centric study design
might have confounded results, this bias was minimized by
standard operating procedures (SOPs) and investigator training.
We applied a shortened and modified 24 item version of the
RMET containing 18 original RMET stimuli and six basic
emotion stimuli. We chose such a combined measure, because
both, ToM and emotion recognition, are similarly impaired in
bvFTD (Henry et al., 2014). We aimed at increasing sensitivity
but might have lost test specificity. Subanalyses could not be
performed due to low item numbers for tests. Applying a
shortened version of the RMET might hamper the detection
of mild or sub-threshold impairments in social cognition.
Accordingly, the 36-item full version of the RMET might be
given preference in the future, especially for mild and pre-
stages such as mild behavioral impairment (Poletti et al., 2013).
Future studies shall also disentangle impairments in ToM and
emotion recognition or cognitive and affective components of
ToM, by applying several tests, because social cognition/ToM
are complex constructs and contain several aspects (Frith and
Frith, 2003; Amodio and Frith, 2006; Poletti et al., 2012; Enrici
et al., 2015). For executive function tests, future studies shall
include additionally tests investigating executive abilities in
daily living settings such as the Behavioral Assessment of the
Dysexecutive Syndrome (BADS) test battery (Schroeter et al.,
2012).
Our study focused on two cognitive dimensions, executive
functions and social cognition without exploring other cognitive
abilities, because these cognitive dimensions have been suggested
as mainly impaired in bvFTD in the literature (Torralva et al.,
2009), and to focus the paper on the most important research
question. Analyzing additionally all other cognitive dimensions
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FIGURE 4 | Discriminatory power as measured with Areas Under the Curve (AUC) as revealed by ROC curves for the total scale and the subscales of the FrSBe.
(attention, memory functions, language) might be a desideratum
for future studies to strengthen our hypothesis.
Our study discriminated patients with bvFTD very well from
healthy controls. One might ask whether such analyses are also
suited to separate patients with possible and probable bvFTD.
To answer this question the same analyses were conducted for
this comparison. Remarkably, no group differences were detected
between possible and probable bvFTD for all neuropsychological
tests and behavioral questionnaires if the same analysis criteria
were applied (in particular Bonferroni correction). The only
parameter that could separate both bvFTD subgroups in the
ROC analyses was phonemic fluency with an AUC of 0.639 and
p = 0.039 (mean values for possible/probable bvFTD 8.64± 4.91,
6.45± 4.73).
A further critical aspect in the general investigation of
bvFTD is that these patients may have a reduced willingness
to participate in a study due to their dysfunctional behavioral
pattern and loss of insight. We assume that a high number of
missing data might actually be due to dysfunctional behavior
in bvFTD patients, in particular in self-report in behavioral
questionnaires. While bvFTD cases had more missing values in
self-reports, healthy controls had more missing values in the
informant-reports, most probably because they had to return
the questionnaires per mail and that they might not have
understood the relevance of their contribution to the study.
Another frequent missing pattern showed TMT missing values
in bvFTD patients, although all other tests were complete. We
assume that in these patients that obviously were compliant,
the TMT was either not assessed or at least stopped due to
a more severe cognitive decline. Furthermore, the data from
some study centers offered a high percentage of identical missing
patterns which suggests a methodological center bias here. Due
to missing values we had to perform separate ROC analyses
instead of a complete case ROC analysis which might be regarded
as a statistical limitation. Although the resulting analyses were
consequently based on slightly differing group constitutions, we
assume, however, that our subsamples were rather homogeneous
and allow comparisons between them.
CONCLUSION
Our study aimed at identifying those neuropsychological and
behavioral parameters with best discriminating power between
bvFTD, defined by new diagnostic criteria, and age-matched
healthy controls in a large multi-centric sample. The study
focussed on executive dysfunction and impairments in social
cognition as most characteristic features of bvFTD. Patients
performed significantly worse than healthy controls in all
neuropsychological tests. Discriminatory power (AUC) was
highest in behavioral questionnaires, followed by verbal fluency
tasks, the social-cognitive RMET and executive function tests
such as the Stroop task, TMT and H5PT. As fluency tasks depend
on several cognitive functions, not only executive functions,
results suggest that the social cognition test – the applied
modified RMET – discriminated better between bvFTD and
controls than ‘proper’ executive tests. Our findings and data
from other studies strengthen the argument that tests for social
cognition, such as the RMET, shall be incorporated into standard
clinical batteries and diagnostic criteria in the future as already
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suggested in bvFTD’s DSM-5 criteria. The study underlines
the diagnostic potential of neuropsychological assessments and
behavioral questionnaires to confirm bvFTD diagnoses in clinical
practice.
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